Scarica l'app Stockscreener
5.05
1.56%
-0.08
Dopo l'orario di chiusura:
5.03
-0.02
-0.40%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$5.13
Aprire:
$5.16
Volume 24 ore:
2.74M
Relative Volume:
0.76
Capitalizzazione di mercato:
$1.22B
Reddito:
$386.15M
Utile/perdita netta:
$-56.39M
Rapporto P/E:
-21.96
EPS:
-0.23
Flusso di cassa netto:
$-55.19M
1 W Prestazione:
-0.20%
1M Prestazione:
-21.34%
6M Prestazione:
+9.78%
1 anno Prestazione:
-13.68%
Intervallo 1D:
$5.01
$5.27
Intervallo di 1 settimana:
$4.7101
$5.27
Portata 52W:
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.05 | 1.21B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
A Look at Ardelyx’s Valuation Following CFO Appointment and Strategic Leadership Shift - simplywall.st
2 Overlooked Stocks To Snap Up In 2025 - Barchart.com
How to build a dashboard for Ardelyx Inc. stockPortfolio Update Report & Verified Chart Pattern Signals - newser.com
Why Ardelyx Inc. (41X) stock signals breakout potentialForecast Cut & AI Forecast for Swing Trade Picks - newser.com
Using Python tools to backtest Ardelyx Inc. strategiesQuarterly Portfolio Summary & AI Enhanced Execution Alerts - newser.com
Ardelyx appoints Sue Hohenleitner as chief financial officer effective November 4 - Investing.com Australia
Ardelyx Appoints New CFO Sue Hohenleitner - TipRanks
Will Ardelyx’s (ARDX) CFO Appointment Shape Its Growth Strategy as Its Portfolio Expands? - Yahoo Finance
Will Ardelyx Inc. stock go up soonQuarterly Market Summary & Reliable Breakout Forecasts - newser.com
Where Does Ardelyx Stand After Its Recent 24% Share Price Drop? - Yahoo Finance
Will Ardelyx’s (ARDX) New CFO Appointment Signal a Shift in Financial Strategy and Growth Priorities? - simplywall.st
Ardelyx (ARDX): Exploring Valuation After Recent Share Price Decline - Yahoo
Ardelyx (NASDAQ:ARDX) Trading Down 3.5%Here's Why - MarketBeat
Ardelyx rises after new CFO appointment - TradingView
Ardelyx, Inc. Announces CFO Changes,Effective November 4, 2025 - MarketScreener
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025 - The Manila Times
Ardelyx, Inc. Appoints Sue Hohenleitner as Chief Financial Officer, Effective November 4, 2025 - Quiver Quantitative
Ardelyx appoints J&J veteran Sue Hohenleitner as new CFO By Investing.com - Investing.com Australia
30+ Years' Finance Leadership: Ardelyx Appoints Sue Hohenleitner as CFO, Starting Nov 4, 2025 - Stock Titan
Is Ardelyx Inc a good long term investmentRisk-Reward Ratio Analysis & Free Rapid Growing Investment Returns - earlytimes.in
Ardelyx, Inc. (NASDAQ:ARDX) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st
Ardelyx Breaks Below 200-Day Moving AverageNotable for ARDX - Nasdaq
Will Ardelyx Inc. continue its uptrendMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Measuring Ardelyx Inc.’s beta against major indices2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Is Ardelyx Inc. stock attractive for ETFsJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
What to do if you’re stuck in Ardelyx Inc.M&A Rumor & Technical Pattern Based Signals - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Ardelyx (NASDAQ:ARDX) - MarketBeat
What analysts say about Ardelyx Inc stockGlobal Market Influence & Free Discover Breakout Stocks Early - earlytimes.in
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Ardelyx (NASDAQ:ARDX) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Short interest data insights for Ardelyx Inc.Weekly Investment Summary & Low Volatility Stock Recommendations - newser.com
Detecting price anomalies in Ardelyx Inc. with AI2025 Year in Review & Fast Gain Swing Trade Alerts - newser.com
Can Ardelyx Inc. hit a new high this monthJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Real time scanner hits for Ardelyx Inc. explained2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Reversal indicators forming on Ardelyx Inc. stockWeekly Earnings Recap & Low Risk Investment Opportunities - newser.com
Volatility clustering patterns for Ardelyx Inc.Bear Alert & Fast Gain Swing Alerts - newser.com
Ardelyx Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Trend Following Techniques - earlytimes.in
Is Ardelyx Inc. forming a reversal patternTrade Analysis Summary & Community Verified Swing Trade Signals - newser.com
Will Ardelyx Inc. rebound enough to break evenTake Profit & Risk Controlled Daily Trade Plans - newser.com
Ardelyx, Inc. Stock Hits Day Low of $5.49 Amid Price Pressure - Markets Mojo
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ardelyx Inc Azioni (ARDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Williams Laura A | Chief Patient Officer |
Aug 26 '25 |
Sale |
6.12 |
80,000 |
489,680 |
366,322 |
| Kelliher Mike | Chief Business Officer |
Aug 21 '25 |
Sale |
5.93 |
5,417 |
32,132 |
276,741 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):